Breast Ductal Carcinoma

Observed

→ investigated in trials for

Letrozolesmall molecule

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Anastrozolesmall molecule

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Afimoxifenesmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Exemestanesmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lapatinibsmall_molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Paclitaxelsmall_molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trastuzumabmonoclonal_antibody

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fulvestrantsmall_molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Hormone Therapy

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Metforminsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Palbociclibsmall_molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Talimogene Laherparepvecgene therapy

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Zoledronic Acidsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abemaciclibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aromatase Inhibitor

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Atezolizumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bexarotenesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Carboplatinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Chloroquinesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Degarelixother

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Docetaxelsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Doxorubicinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipilimumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nivolumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pembrolizumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pemetrexedsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ruxolitinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Breast Ductal Carcinoma studied in …STUDIED_INderived10 of 210show all (up to 200)
→ studied in	NCT07214532NA · recruiting Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer · condition mapped ALIAS · 210 trials mapped (70 active)	—	—	Breast Ductal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07711847NA · recruiting Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy · condition mapped ALIAS · 210 trials mapped (70 active)	—	—	Breast Ductal Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT03455270Phase 1 · completed G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer · condition mapped ALIAS · 210 trials mapped (70 active)	—	—	Breast Ductal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04084730Phase 2 · recruiting Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer · condition mapped ALIAS · 210 trials mapped (70 active)	—	—	Breast Ductal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03077841Phase 2/Phase 3 · suspended Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer · condition mapped ALIAS · 210 trials mapped (70 active)	—	—	Breast Ductal Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT06902311Phase 2 · recruiting Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST) · condition mapped ALIAS · 210 trials mapped (70 active)	—	—	Breast Ductal Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT02750826Phase 3 · active not recruiting Breast Cancer WEight Loss Study (BWEL Study) · condition mapped ONTOLOGY_EXACT · 210 trials mapped (70 active)	—	—	Breast Ductal Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT03317405Phase 1 · active not recruiting Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery · condition mapped ONTOLOGY_EXACT · 210 trials mapped (70 active)	—	—	Breast Ductal Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT05837767NA · recruiting A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue · condition mapped ALIAS · 210 trials mapped (70 active)	—	—	Invasive Breast Carcinoma of No Special Type	1	Observed	clinicaltrials	graph →
→ studied in	NCT06671912Phase 3 · suspended Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial · condition mapped ONTOLOGY_EXACT · 210 trials mapped (70 active)	—	—	Breast Ductal Carcinoma In Situ	1	Observed	clinicaltrials	graph →

Breast Ductal Carcinoma studied in …STUDIED_INderived10 of 210show all (up to 200)

→ studied in

NCT07214532NA · recruiting

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer · condition mapped ALIAS · 210 trials mapped (70 active)

—

Observed

→ studied in

NCT07711847NA · recruiting

Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy · condition mapped ALIAS · 210 trials mapped (70 active)

—

Observed

→ studied in

NCT03455270Phase 1 · completed

G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer · condition mapped ALIAS · 210 trials mapped (70 active)

—

Observed

→ studied in

NCT04084730Phase 2 · recruiting

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer · condition mapped ALIAS · 210 trials mapped (70 active)

—

Observed

→ studied in

NCT03077841Phase 2/Phase 3 · suspended

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer · condition mapped ALIAS · 210 trials mapped (70 active)

—

Observed

→ studied in

NCT06902311Phase 2 · recruiting

Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST) · condition mapped ALIAS · 210 trials mapped (70 active)

—

Observed

→ studied in

NCT02750826Phase 3 · active not recruiting

Breast Cancer WEight Loss Study (BWEL Study) · condition mapped ONTOLOGY_EXACT · 210 trials mapped (70 active)

—

Observed